Robert Wilbur, Pharm.D., CPh. | Executive Director, Medical Affairs
Robert received his Bachelors of Science degree from the University of South Florida, Doctorate of Pharmacy degree from Mercer University, and completed a Clinical Residency at Emory University.
Through his 27 years in the profession of pharmacy, Robert has been involved in almost every facet of the industry. He has served as the Chief Clinical Pharmacist for a large metropolitan hospital, conducted clinical drug trials, consulted for three international pharmaceutical companies, and was a Vice President for an international healthcare company.
Robert is now the Executive Director of Medical Affairs for Gensco Laboratories.
Gensco Executive Team
Paul Zimmerman, M.D. | Chairman & CEO bio »
Frank Aguilar | VP, National Accounts
Crystal Lore | VP, Business Development bio »
Robert L. Wilbur, Pharm.D., CPh | Executive Director, Medical Affairs bio »
David A. Andry | Senior Director National Accounts
Lewis Archibeck | Sr. Sales Executive
Lisa Capote, Esq | General Counsel
- Gensco® Pharma Announces RizaFilm® Commercialization Update in the United States September 26, 2023 Featured, Industry, Press Release, Product Update - Gensco® Pharma, a specialty pharmaceutical company, in partnership with IntelGenx is announcing the anticipated launch… more...
- Skin Tears Treatment Market to Observe Strong Development by 2018-2026 April 15, 2019 Articles, Featured, Industry - [To download a printable version of this article, click here] MARKET RESEARCH April 12, 2019… more...
- Gensco® Pharma Partners with IntelGenx to Launch and Commercialize RIZAFILM® (U.S. market name for RIZAPORT® — Rizatriptin Oral Film) in the United States December 12, 2018 Featured, Industry, Press Release, Product Update - Miami, Florida, December 12, 2018 – Gensco® Pharma, a leading specialty pharmaceutical manufacturer specializing in… more...
- AAP Issues Flu Vaccine Recommendations for 2018-2019 September 6, 2018 Articles, Industry - All children should receive the flu shot as soon as it is available: AAP [To… more...